Belluscura (BELL) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Dec 2024 03:20 PM
RNS
Appointment of Allenby Capital as Joint Broker
11 Dec 2024 03:21 PM
RNS
Holding(s) in Company
03 Dec 2024 07:00 AM
RNS
New Wound Care Joint Venture
22 Nov 2024 07:00 AM
RNS
New $4million Credit Facility
12 Nov 2024 04:34 PM
RNS
Holding(s) in Company
28 Oct 2024 07:00 AM
RNS
Trading Update
26 Sep 2024 07:00 AM
RNS
Half-year Report
13 Sep 2024 01:37 PM
RNS
Holding(s) in Company
12 Sep 2024 03:05 PM
RNS
Holding(s) in Company
27 Aug 2024 02:17 PM
RNS
Result of General Meeting
27 Aug 2024 07:00 AM
RNS
AGM Trading Statement
02 Aug 2024 07:00 AM
RNS
Notice of AGM
31 Jul 2024 01:11 PM
RNS
Total Voting Rights
19 Jul 2024 10:36 AM
RNS
Director/PDMR Shareholding
11 Jul 2024 11:30 AM
RNS
Directorate Change
08 Jul 2024 12:45 PM
RNS
Result of General Meeting
04 Jul 2024 01:30 PM
RNS
Director/PDMR Shareholding
02 Jul 2024 02:30 PM
RNS
Conditional placing of unsecured CLNs
01 Jul 2024 02:10 PM
RNS
Total Voting Rights
27 Jun 2024 07:00 AM
RNS
Final Results
25 Jun 2024 03:34 PM
RNS
Holding(s) in Company
24 Jun 2024 07:00 AM
RNS
Update re proposed placing of CLNs
14 Jun 2024 01:45 PM
RNS
Posting of Circular and Notice of General Meeting
12 Jun 2024 07:00 AM
RNS
Trading update and proposed placing
17 Apr 2024 07:00 AM
RNS
Belluscura Concert Party
11 Apr 2024 10:23 AM
RNS
Holding(s) in Company
08 Apr 2024 01:15 PM
RNS
Holding(s) in Company
05 Apr 2024 04:40 PM
RNS
Holding(s) in Company
05 Apr 2024 03:48 PM
RNS
Issue of Equity
02 Apr 2024 07:00 AM
RNS
Trading Update
28 Mar 2024 07:00 AM
RNS
Total Voting Rights
08 Mar 2024 04:36 PM
RNS
Offer Closed
07 Mar 2024 08:30 AM
RNS
Cancellation of Listing and trading
04 Mar 2024 07:00 AM
RNS
Acceptances level
26 Feb 2024 07:00 AM
RNS
Acceptances level
22 Feb 2024 03:00 PM
RNS
Acceptances level, issue of equity & AIM Admission
19 Feb 2024 07:00 AM
RNS
Acceptances level & offer closing
15 Feb 2024 03:51 PM
RNS
Acceptances level, issue of equity & AIM Admission
13 Feb 2024 07:00 AM
RNS
Distribution Agreement & New VP North America
13 Feb 2024 07:00 AM
RNS
Acceptances Level
12 Feb 2024 01:44 PM
GNW
Form 8.3 - Belluscura PLC
12 Feb 2024 07:00 AM
RNS
Acceptances Level
09 Feb 2024 08:16 AM
RNS
Offer becomes wholly unconditional
08 Feb 2024 03:31 PM
RNS
Acceptances level, issue of equity & AIM Admission
07 Feb 2024 04:20 PM
RNS
Offer Unconditional (subject to AIM Admission)
07 Feb 2024 11:13 AM
RNS
Form 8.3 - Belluscura Plc
05 Feb 2024 01:30 PM
RNS
Result of General Meeting
05 Feb 2024 07:00 AM
RNS
Acceptances received in respect of the Offer
02 Feb 2024 11:24 AM
RNS
Form 8 (OPD) Belluscura plc
02 Feb 2024 11:18 AM
RNS
Form 8 (OPD) TMT Acquisition plc

Belluscura is a medical device company based in the United States that was founded in the United Kingdom. The Company is focused on developing lightweight and portable oxygen enrichment technology.

Belluscura share price launched in London at 53p in 2021.

UK 100

Latest directors dealings